Thorne HealthTech Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Paul Jacobson
Chief executive officer
US$4.1m
Total compensation
| CEO salary percentage | 13.0% |
| CEO tenure | 13.8yrs |
| CEO ownership | n/a |
| Management average tenure | 9.8yrs |
| Board average tenure | 8.4yrs |
Recent management updates
Recent updates
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 12
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar
Jun 07Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist
Dec 17Thorne HealthTech Grows But Faces Macro Headwinds
Sep 09Thorne HealthTech's blood collection device OneDraw gets clearance in Japan
Aug 23Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised
Aug 09Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Jun 05Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality
Mar 23Thorne HealthTech: Good Potential At A Low Price
Jan 11CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | US$20m |
| Mar 31 2023 | n/a | n/a | US$10m |
| Dec 31 2022 | US$4m | US$530k | US$16m |
| Sep 30 2022 | n/a | n/a | US$6m |
| Jun 30 2022 | n/a | n/a | US$3m |
| Mar 31 2022 | n/a | n/a | US$9m |
| Dec 31 2021 | US$13m | US$530k | US$4m |
| Sep 30 2021 | n/a | n/a | -US$822k |
| Jun 30 2021 | n/a | n/a | -US$1m |
| Mar 31 2021 | n/a | n/a | -US$3m |
| Dec 31 2020 | US$759k | US$530k | -US$3m |
Compensation vs Market: Paul's total compensation ($USD4.09M) is above average for companies of similar size in the US market ($USD2.23M).
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Jacobson (68 yo)
13.8yrs
Tenure
US$4,088,000
Compensation
Mr. Paul F. Jacobson Co-Founded Thorne HealthTech, Inc. in 2010 and has been its Chief Executive Officer and Director since 2010. He is Chairman of Thorne HealthTech, Inc. He was Interim Principal Financi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$4.09m | no data | |
| President | no data | US$1.35m | no data | |
| CFO & Director | less than a year | US$463.20k | 0.032% $ 173.4k | |
| COO & Director | 13.8yrs | US$2.89m | no data | |
| Chief Technology Officer | 9.8yrs | no data | no data | |
| Chief Scientific Officer & CEO of Onegevity | no data | no data | no data | |
| VP & Head of Investor Relations | no data | no data | no data | |
| General Counsel | 28.8yrs | no data | no data | |
| Chief Marketing Officer | 5.9yrs | no data | no data | |
| Senior VP of Professional Sales | no data | no data | no data | |
| Chief Strategy Officer | no data | no data | no data | |
| Chief Innovation Officer | 2.8yrs | no data | no data |
9.8yrs
Average Tenure
45.5yo
Average Age
Experienced Management: THRN's management team is seasoned and experienced (9.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.8yrs | US$4.09m | no data | |
| CFO & Director | 2.1yrs | US$463.20k | 0.032% $ 173.4k | |
| COO & Director | 13.8yrs | US$2.89m | no data | |
| Independent Director | 11.8yrs | no data | 0% $ 0 | |
| Independent Director | 2.1yrs | US$469.45k | 0.021% $ 114.6k | |
| Independent Director | 5yrs | no data | 0% $ 0 |
8.4yrs
Average Tenure
58.5yo
Average Age
Experienced Board: THRN's board of directors are considered experienced (8.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/18 03:10 |
| End of Day Share Price | 2023/10/13 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Thorne HealthTech, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Bryan Spillane | BofA Global Research |
| Susan Anderson | Canaccord Genuity |